Ken Griffin acquired 1.18 Million Beam Therapeutics shares worth $34.8 Million. That's 0.04% of their equity portfolio (546th largest holding). The investor owns 1.52% of the outstanding Beam Therapeutics stock. The first Beam Therapeutics trade was made in Q1 2020. Since then Ken Griffin bought shares eight more times and sold shares on five occasions. The investor's estimated purchase price is $55.4 Million, resulting in a loss of 37%.